Mettler-Toledo International Inc. boasts exceptional capital efficiency, delivering high returns on invested capital with minimal reinvestment needs, similar to Buffett's See's Candy. The company's strong competitive moat is reinforced by global reach, specialized marketing, and expanding high-margin service offerings. MTD consistently generates robust free cash flow, prioritizing significant s...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as re...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE: MTD) is a leading global...
Mettler-Toledo has a strong moat with high gross margins (60%) and operating margins (30%), driven by dominant positions in laboratory and industrial scales. The company's valuation has become more attractive as earnings per share have improved while the stock price remained stagnant since 2020. MTD's capital allocation focuses on share repurchases, reducing share count by 25% since 2016, ensur...
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Inv...
Mettler-Toledo International Inc. (NYSE:MTD ) Q4 2024 Earnings Conference Call February 7, 2025 8:30 AM ET Company Participants Adam Uhlman - Head of IR Patrick Kaltenbach - CEO Shawn Vadala - CFO Conference Call Participants Vijay Kumar - Evercore Dan Arias - Stifel Jack Meehan - Nephron Research Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Josh Waldman - Cleveland Research Patrick Do...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.